4-PIPERAZINYLTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) wherein A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2l, R4, R5, and R6 are as defined in the detailed description of the invention. Corresponding pharmaceutical c...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ENNIS, MICHAEL, DALTON KORTUM, STEVEN, WADE TENBRINK, RUTH, ELIZABETH |
| description | Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) wherein A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2l, R4, R5, and R6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
L'invention concerne des composés et des sels pharmaceutiquement tolérables desdits composés. Lesdits composés présentent la structure de formule (I), dans laquelle A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2l, R4, R5 et R6 figurent comme définis dans la description détaillée de l'invention. L'invention concerne des compositions pharmaceutiques correspondantes, des procédés de traitement, des procédés de synthèse, ainsi que des produits intermédiaires. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2006103544A8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2006103544A8</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2006103544A83</originalsourceid><addsrcrecordid>eNqNyrEKwjAQANAuDqL-w4Grhdim4hqbMz1ok5CeSBUpReIkWqj_j4sf4PSWN09Ypp48BnUh29VcEVoH12wDeapv4LtADWmyCKVrvDtZ3YJqwdeKsUYGZUxAo5icBbIVHYhdaJfJ7DE8p7j6uUjWR-SySuP47uM0Dvf4ip_-7DIhdluRF1Kqff7f-gL0CzEo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>4-PIPERAZINYLTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS</title><source>esp@cenet</source><creator>ENNIS, MICHAEL, DALTON ; KORTUM, STEVEN, WADE ; TENBRINK, RUTH, ELIZABETH</creator><creatorcontrib>ENNIS, MICHAEL, DALTON ; KORTUM, STEVEN, WADE ; TENBRINK, RUTH, ELIZABETH</creatorcontrib><description>Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) wherein A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2l, R4, R5, and R6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
L'invention concerne des composés et des sels pharmaceutiquement tolérables desdits composés. Lesdits composés présentent la structure de formule (I), dans laquelle A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2l, R4, R5 et R6 figurent comme définis dans la description détaillée de l'invention. L'invention concerne des compositions pharmaceutiques correspondantes, des procédés de traitement, des procédés de synthèse, ainsi que des produits intermédiaires.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071018&DB=EPODOC&CC=WO&NR=2006103544A8$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071018&DB=EPODOC&CC=WO&NR=2006103544A8$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ENNIS, MICHAEL, DALTON</creatorcontrib><creatorcontrib>KORTUM, STEVEN, WADE</creatorcontrib><creatorcontrib>TENBRINK, RUTH, ELIZABETH</creatorcontrib><title>4-PIPERAZINYLTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS</title><description>Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) wherein A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2l, R4, R5, and R6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
L'invention concerne des composés et des sels pharmaceutiquement tolérables desdits composés. Lesdits composés présentent la structure de formule (I), dans laquelle A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2l, R4, R5 et R6 figurent comme définis dans la description détaillée de l'invention. L'invention concerne des compositions pharmaceutiques correspondantes, des procédés de traitement, des procédés de synthèse, ainsi que des produits intermédiaires.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQANAuDqL-w4Grhdim4hqbMz1ok5CeSBUpReIkWqj_j4sf4PSWN09Ypp48BnUh29VcEVoH12wDeapv4LtADWmyCKVrvDtZ3YJqwdeKsUYGZUxAo5icBbIVHYhdaJfJ7DE8p7j6uUjWR-SySuP47uM0Dvf4ip_-7DIhdluRF1Kqff7f-gL0CzEo</recordid><startdate>20071018</startdate><enddate>20071018</enddate><creator>ENNIS, MICHAEL, DALTON</creator><creator>KORTUM, STEVEN, WADE</creator><creator>TENBRINK, RUTH, ELIZABETH</creator><scope>EVB</scope></search><sort><creationdate>20071018</creationdate><title>4-PIPERAZINYLTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS</title><author>ENNIS, MICHAEL, DALTON ; KORTUM, STEVEN, WADE ; TENBRINK, RUTH, ELIZABETH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2006103544A83</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ENNIS, MICHAEL, DALTON</creatorcontrib><creatorcontrib>KORTUM, STEVEN, WADE</creatorcontrib><creatorcontrib>TENBRINK, RUTH, ELIZABETH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ENNIS, MICHAEL, DALTON</au><au>KORTUM, STEVEN, WADE</au><au>TENBRINK, RUTH, ELIZABETH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>4-PIPERAZINYLTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS</title><date>2007-10-18</date><risdate>2007</risdate><abstract>Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) wherein A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2l, R4, R5, and R6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
L'invention concerne des composés et des sels pharmaceutiquement tolérables desdits composés. Lesdits composés présentent la structure de formule (I), dans laquelle A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2l, R4, R5 et R6 figurent comme définis dans la description détaillée de l'invention. L'invention concerne des compositions pharmaceutiques correspondantes, des procédés de traitement, des procédés de synthèse, ainsi que des produits intermédiaires.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2006103544A8 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 4-PIPERAZINYLTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T14%3A44%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ENNIS,%20MICHAEL,%20DALTON&rft.date=2007-10-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2006103544A8%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |